Carregant...
LRRK2 activity does not dramatically alter α-synuclein pathology in primary neurons
Mutations in leucine-rich repeat kinase (LRRK2) are the most common cause of heritable Parkinson’s disease (PD), and the most common mutations in LRRK2 lead to elevated kinase activity. For these reasons, inhibitors targeting LRRK2 have been the subject of intense research and development. However,...
Guardat en:
| Publicat a: | Acta Neuropathol Commun |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5984465/ https://ncbi.nlm.nih.gov/pubmed/29855356 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40478-018-0550-0 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|